Novartis Ag NVS
NYSE NVS
$137.50 +0.02 (+0.01%)
As of: Sep 10, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026)

Novartis Ag's (NVS) quarterly Dividends Paid - Common came in at -$2.9 billion in Q2 2026, down 15.53% year-over-year from -$3.4 billion in Q2 2025, and up 53.67% quarter-over-quarter from -$6.2 billion in Q1 2026.

Analysis

Novartis Ag (NVS) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed Dividends Paid - Common across 18 years of filings, most recently posting -$2.9 billion for Q2 2026.

  • In Q2 2026, Dividends Paid - Common fell 15.53% year-over-year to -$2.9 billion; the TTM figure through Jun 2026 stood at -$16.9 billion (down 9.35% YoY), while the FY2025 annual figure was -$7.8 billion, down 2.54% from the prior year.
  • Dividends Paid - Common came in at -$2.9 billion for Q2 2026 at Novartis Ag, up from -$6.2 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of -$2.4 billion in Q2 2024 to a low of -$7.8 billion in Q4 2025.
  • Average Dividends Paid - Common over 5 years is -$5.5 billion, with a median of -$5.8 billion recorded in 2025.
  • Year-over-year, Dividends Paid - Common grew 28.23% in 2024 and retreated 16.2% in 2026.
  • Over 5 years, Dividends Paid - Common stood at -$7.5 billion in 2022, then increased by 3.34% to -$7.3 billion in 2023, then fell by 5.09% to -$7.6 billion in 2024, then fell by 2.54% to -$7.8 billion in 2025, then soared by 63.28% to -$2.9 billion in 2026.
  • Per Business Quant data, the three most recent Dividends Paid - Common figures were -$2.9 billion in Q2 2026, -$6.2 billion in Q1 2026, and -$7.8 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 3.23 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 3.07 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -2.87 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 2.45 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 6.09 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.87 Bn
Mar 31, 2026 -6.20 Bn
Dec 31, 2025 -7.82 Bn
Jun 30, 2025 -2.49 Bn
Mar 31, 2025 -5.33 Bn
Dec 31, 2024 -7.62 Bn
Jun 30, 2024 -2.42 Bn
Mar 31, 2024 -5.21 Bn
Mar 31, 2023 -7.26 Bn
Mar 31, 2022 -7.51 Bn
Mar 31, 2021 -7.37 Bn
Dec 31, 2020 13.99 Bn
Mar 31, 2020 -6.99 Bn
Dec 31, 2019 -6.65 Bn
Mar 31, 2019 -6.65 Bn
Mar 31, 2018 -6.97 Bn
Mar 31, 2017 -6.50 Bn
Dec 31, 2016 -6.48 Bn
Mar 31, 2016 -6.48 Bn
Dec 31, 2015 -6.64 Bn